We read with great interest the thorough review by Roubey ’ on the antiphospholipid syndrome. However, we would like to comment on one point. To explain why autoantibodies to pure &glycoprotein I (O,-GPI) may be detected by enzyme-linked immunosorbent assay (ELISA) only when &GP1 is coated on irradiated plates, Roubey supports the first possibility, ie, that the antibodies require a rela-tively high density of immobilized antigen that cannot be achieved on untreated polystyrene. We present data that support the second possibility, ie, that the antibodies are specific for a conformational epitope of &GP1 formed when the protein is bound to an anionic surface, such as irradiated polystyrene or cardiolipin. Two monoclonal antibodie...
It has become clear that β2-glycoprotein I (β2GPI) is the most common and best-cha...
The precise target of marker autoantibodies in the antiphospholipid syndrome (APS) has been controve...
A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between c...
The clinical significance of anti-/J2 glycoprotein I (/?2-GPI) antibodies was evaluated in patients ...
Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipi...
The antiphospholipid antibodies (aPL) present in autoimmune disorders are associated with thromboemb...
b2-Glycoprotein I (b2-GPI), a plasma protein with in vitro anticoagulant properties, has been recogn...
Autoantibodies binding b2-glycoprotein I (B2GPI) are an important nding in the antiphospholipid syn...
The antiphospholipid syndrome (APS) is diagnosed by the occurrence of thrombosis and/or specific pre...
In this issue ofBlood, Ağar and colleagues present data for a novel explanation of how an antigenic...
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease clinically characterized b...
A subset of patients with systemic lupus erythematosus has autoantibodies to acidic phospholipids. S...
OBJECTIVE: It has been suggested that only antibodies against domain 1 (D1) of β2 -glycoprotein I (β...
Beta-2 glycoprotein I (\u3b22GPI) is the main antigenic target for anti-phospholipid antibodies (aPL...
Antiphospholipid syndrome is characterized by a prothrombotic state and the presence of β2-...
It has become clear that β2-glycoprotein I (β2GPI) is the most common and best-cha...
The precise target of marker autoantibodies in the antiphospholipid syndrome (APS) has been controve...
A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between c...
The clinical significance of anti-/J2 glycoprotein I (/?2-GPI) antibodies was evaluated in patients ...
Anticardiolipin antibodies (aCL) derived from the sera of individuals exhibiting the antiphospholipi...
The antiphospholipid antibodies (aPL) present in autoimmune disorders are associated with thromboemb...
b2-Glycoprotein I (b2-GPI), a plasma protein with in vitro anticoagulant properties, has been recogn...
Autoantibodies binding b2-glycoprotein I (B2GPI) are an important nding in the antiphospholipid syn...
The antiphospholipid syndrome (APS) is diagnosed by the occurrence of thrombosis and/or specific pre...
In this issue ofBlood, Ağar and colleagues present data for a novel explanation of how an antigenic...
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disease clinically characterized b...
A subset of patients with systemic lupus erythematosus has autoantibodies to acidic phospholipids. S...
OBJECTIVE: It has been suggested that only antibodies against domain 1 (D1) of β2 -glycoprotein I (β...
Beta-2 glycoprotein I (\u3b22GPI) is the main antigenic target for anti-phospholipid antibodies (aPL...
Antiphospholipid syndrome is characterized by a prothrombotic state and the presence of β2-...
It has become clear that β2-glycoprotein I (β2GPI) is the most common and best-cha...
The precise target of marker autoantibodies in the antiphospholipid syndrome (APS) has been controve...
A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between c...